Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2024-04-24 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2023 by 九芝堂股份有限公司. It contains detailed information about the company's internal control evaluation, including scope, standards, identified deficiencies, and corrective actions. The content is focused on internal control effectiveness and compliance with regulatory standards, rather than being a full annual report or financial statement. It is not a brief announcement or a certification letter but a substantive report on internal control. This fits the description of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations. The document length (4656 characters) is sufficient to contain detailed substantive content, not just an announcement. Therefore, the appropriate classification is AR with high confidence. FY 2023
2024-04-24 Chinese
董事会审计委员会对会计师事务所2023年度履职情况评估及履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee evaluating the performance of the external audit firm for the fiscal year 2023. It discusses the audit firm's qualifications, the audit procedures performed, findings including internal control deficiencies, and the committee's oversight and evaluation of the audit firm's work. The document references the 2023 annual audit and internal control audit but does not contain the full annual report or financial statements itself. It is a standalone report focused on audit and supervisory activities related to the audit firm, consistent with an Audit Report / Information filing rather than a full Annual Report or other categories. The document length (2444 characters) and content confirm it is not an announcement or certification but a substantive audit committee report on audit firm performance and supervision. FY 2023
2024-04-24 Chinese
2023年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the "2023年度财务决算报告" (2023 Annual Financial Settlement Report) of 九芝堂股份有限公司, which includes detailed financial data such as revenue, profit, assets, liabilities, cash flow, and accounting policy changes. It mentions the audit by an independent accounting firm with an unqualified opinion, and provides comprehensive financial statements and analysis for the full fiscal year 2023. The length is over 7,700 characters, indicating it is a full report rather than a brief announcement. The content matches the characteristics of an Annual Report (10-K) as it covers the company's full financial performance and condition for the year. Therefore, the document should be classified as an Annual Report (10-K). FY 2023
2024-04-24 Chinese
关于2023年度日常关联交易确认及2024年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement by 九芝堂股份有限公司 regarding the confirmation of 2023 daily related party transactions and the forecast of 2024 daily related party transactions. It includes detailed descriptions of the related party, transaction amounts, pricing principles, board meeting approvals, and independent director opinions. The document is regulatory in nature, disclosing ongoing related party transactions and their compliance with stock exchange rules. It does not contain financial statements, audit opinions, or full financial reports. It is not a report publication announcement since it contains substantive disclosure rather than just a notice of report availability. The document fits best into the category of Regulatory Filings (RNS) as it is a compliance disclosure about related party transactions required by stock exchange rules and corporate governance, but not a financial report or management report.
2024-04-24 Chinese
关于公司股票交易将被实施其他风险警示暨股票停牌的提示性公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 九芝堂股份有限公司 regarding the implementation of a risk warning on its stock due to a negative internal control audit report issued by an accounting firm. It details the reasons for the risk warning, stock suspension and resumption dates, changes in stock trading rules, and corrective measures taken by the company. The document does not contain full financial statements or detailed financial performance data but is an official regulatory announcement about stock trading status and risk warnings. It is relatively short (3599 characters) and serves as a notice to investors and the market about the stock's risk status and trading suspension/restart. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories like Annual Report or Audit Report.
2024-04-24 Chinese
关于公司向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's application for a comprehensive credit facility with banks, including details about the credit amount, approval procedures, and authorization. It is a financing-related update rather than a financial report or regulatory filing. The document is short (661 characters) and focuses on capital/financing activities. Therefore, it fits best under Capital/Financing Update (CAP).
2024-04-24 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.